A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Luciferase Assay for Measuring γ-Secretase Activity in Human Cells

639 views

July 8th, 2025

In This Article

Abstract

Source: Wang, B., et al., Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms. J. Vis. Exp. (2018).

This video demonstrates the procedure of measuring γ-secretase activity in genetically modified human cells using a tetracycline-inducible system. The process involves inducing APP gene expression with tetracycline, generating amyloid-β peptides, and activating luciferase production. The bioluminescence resulting from the luciferase-substrate reaction is then measured, reflecting γ-secretase activity.

Protocol

All procedures involving sample collection have been performed in accordance with the institute's IRB guidelines. 

1. Measurement of Luciferase Reporter Signals, which Correspond to γ-Secretase Cleavage of APP-C99 (amyloid precursor protein - C-terminal 99-amino acid fragment)

NOTE: Please refer to the previous publications for detailed descriptions of the generation of CG (C99-Gal4) cells.

  1. Seed CG cells (20, 000 cells/well) onto 96-well microplates at a final volume of 200 μL/well in growth medium that is composed of Dulbecco's Modified Eagle Medium (DMEM) plus 10% fetal bovine serum (FBS), 5 μg/mL blasticidin, 250 μg/mL antibiotic (e.g., zeocin), and 200 μg/mL hygromycin B.
    1. Count cells with a hemocytometer.
    2. Transfer the microplates to a humidified CO2 incubator and incubate at 37 °C overnight.
  2. Remove 100 μL of growth medium from each well.
  3. Add 100 μL/well of growth medium containing 2 μg/mL tetracycline with either 0.2% dimethyl sulfoxide (DMSO), 2 μM CL-387,785, 2 μM N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butylester (DAPT), or other related ErbB1/ErbB2 inhibitors.
  4. Incubate treated CG cells in microplates at 37 °C for 24 h.
  5. Remove 150 μL/well growth medium from microplates.
  6. Add 50 μL/well luciferase assay reagent (please see Table of Materials).
  7. Transfer the microplates to a luminescence microplate reader.
    1. Maintain the microplates at room temperature for 5 min with gentle agitation.
  8. Determine the Firefly luciferase (FL)-emitted luminescence using a pre-defined program stored in the luminescence microplate reader.

Access restricted. Please log in or start a trial to view this content.

Disclosures

No conflicts of interest declared.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
VictorLight luminescence plate readerPerkinElmer2030-0010
Class II, Type 2 Biological Safety CabinetThermo Scientific1300 Series A2
CL-387,785EMD Calbiochem233100-1MG
DAPTMerck565770
Dulbecco's Modified Eagle Medium (DMEM)Thermo Fisher12100046main compnent of growth medium
Fetal bovine serum (FBS)Thermo Fisher16000044
BlasticidinThermo FisherA1113903
ZeocinThermo FisherR25005
Hygromycin BGibco10687010
HemocytomerSigma-AldrichBR717805 Aldrich
96-well microplateNunc156545
TetracyclineSigmaT7660
Dimethyl sulfoxide (DMSO)SigmaD2650
Steady-Glo luciferase assay reagentPromegaE2510
Humidified CO2 incubatorRevcoUltima II
T-REx293 cell lineInvitrogenR71007
Wallac 1420 software version 3.0PerkinElmerinstrument control software of the luminescence microplate reader

Tags

Gamma Secretase ActivityTetracycline Inducible SystemAmyloid Precursor ProteinBioluminescence MeasurementMicroplate ReaderCell Based AssayGamma Secretase InhibitorsAPP Gene ExpressionLuciferase Substrate Reaction